These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30762284)

  • 1. Aspirin in childhood acute ischemic stroke: The evidence for treatment and efficacy testing.
    Boucher AA; Taylor JM; Luchtman-Jones L
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27665. PubMed ID: 30762284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet agents for prevention of recurrent ischemic stroke.
    Hegge KA
    S D Med; 2009 Jan; 62(1):15-7. PubMed ID: 19245087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy?
    Milionis H; Michel P
    Curr Pharm Des; 2013; 19(21):3788-94. PubMed ID: 23286434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic, rather than laboratory-defined resistance drives aspirin failure in ischemic stroke.
    Agayeva N; Gungor L; Topcuoglu MA; Arsava EM
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):745-50. PubMed ID: 25680657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study.
    Rosafio F; Lelli N; Mimmi S; Vandelli L; Bigliardi G; Dell'Acqua ML; Picchetto L; Pentore R; Ferraro D; Trenti T; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1864-1873. PubMed ID: 28576652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
    Castilla-Guerra L; Fernandez-Moreno Mdel C; Navas-Alcantara MS; Jimenez-Gonzalo F
    Eur J Intern Med; 2014 Mar; 25(3):e40-1. PubMed ID: 24484620
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
    Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
    Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
    Liu F; Tantry US; Gurbel PA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1149-65. PubMed ID: 25873127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
    Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.
    Ansara AJ; Nisly SA; Arif SA; Koehler JM; Nordmeyer ST
    Ann Pharmacother; 2010 May; 44(5):851-62. PubMed ID: 20388864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
    Hankey GJ
    Stroke; 2002 Jun; 33(6):1723-6. PubMed ID: 12053018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.